News

AddToAny

Google+ Facebook Twitter Twitter

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemotherapy to treat an aggressive form of adult leukem

Drugs developed to treat heart and blood vessel problems could be used in combination with chemotherapy to treat an aggressive form of adult leukemia.

The claim comes from new research led by the Francis Crick Institute.

The team discovered that acute myeloid leukemia (AML) causes bone marrow to “leak” blood, preventing chemotherapy being delivered properly.

Drugs that reversed bone marrow leaking boosted the effect of chemotherapy in mice and human tissue, providing a possible new combination therapy for AML patients.

Diana Passaro, lead author, said: “The cancer was damaging the walls of blood vessels responsible for delivering oxygen, nutrients, and chemotherapy. When we used drugs to stop the leaks in mice, we were able to kill the cancer using conventional chemotherapy.”

As the drugs are already in clinical trials for other conditions, it is hoped that they could be given the green light for AML patients in the future.

The study has been published in Cancer Cell.

bit.ly/BS_ OctNews6

Related Articles

Cila Vircell

New serology assays

Vircell has added a number of new assays to its VirClia range, enhancing the extensive portfolio of chemiluminescent monotests for infectious disease serology.

Beta cells strand

Blood glucose and type 1 diabetes

A study shows that a gene therapy approach can lead to long-term survival for functional beta cells, as well as normal blood glucose levels for an extended period of time in mice with type 1 diabetes. 

Triple negative breast cancer cell

Fighting breast cancer

A combination of oncolytic viruses and checkpoint inhibitors could be more successful than traditional treatments in fighting breast cancer, and possibly other cancers too.

Science news in numbers

Science news in numbers: February

A breakdown of science news this month.

Top